Document is current
Any future updates will be listed below
-
Authors
Lu, Ruoyu
Wang, Ziqi
Tian, Wentao
Shi, Wen
Chu, Xianjing
Zhou, Rongrong
-
Funding
Funding for this research was provided by:
National Multidisciplinary Cooperative Diagnosis and Treatment Capacity (lung cancer z027002)
Clinical Research Special Fund of Wu Jieping Medical Foundation (320.6750.2023-5-109)
National Clinical Research Center for Geriatric Disorders (No. 2022LNJJ10)
Health Research Project of Hunan Provincial Health Commission (W20242005)
Advanced Lung Cancer Targeted Therapy Research Foundation of China (CTONG-YC20210303)
Chen Xiao-Ping Foundation for the Development of Science and Technology of Hubei Province (CXPJJH121005-01)
- License Information
-
More Information
Article History
Received: 15 July 2024
Accepted: 24 February 2025
First Online: 27 February 2025
Declarations
:
: The authors declare no competing interests.
: This study was conducted in accordance with the guidelines of the Declaration of Helsinki. All methods were performed in accordance with the relevant guidelines and regulations. The study protocol was approved by the ethics committee of Xiangya Hospital, Central South University (202406122). In accordance with the Ethical Review Methodology for Biomedical Research Involving Humans (2016 Edition) established by the Chinese authorities, the Ethics Committee of Xiangya Hospital, Central South University granted approval for the waiver of patient consent.
